Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Quarterly News Letter

<< Previous

Bullboard Posts

Next >>

Comment by toade1313on Aug 17, 2021 9:23am

320 Views

Post# 33716034

RE:Quarterly News Letter

Good luck with that. A quarterly report should be about the quarter being reported NOT the current quarter. If there is something on the horizon that is important a PRESS RELEASE would be totally acceptable. Many over the years have not been impressed with this managements communications. Of course this is just my opinion but it's also why I no longer have 2.7 million shares.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks